Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
IVX | Ann: INV043 With ICI Therapy Achieved 80% Tumour Control For ASCC | 07/03/24 | 17 | 4.5K | |||
|
|||||||
IVX | Ann: Presentation at East-West Summit in Singapore | 05/03/24 | 0 | 223 | |||
|
|||||||
IVX Biotech | ACHIEVING ~80% TUMOUR CONTROL IN PRECLINICAL STUDIES | 05/03/24 | 0 | 168 | |||
|
|||||||
IVX | Ann: Appendix 4D and Half Year Financial Report | 28/02/24 | 0 | 206 | |||
|
|||||||
IVX | Ann: Agreement with Dr.inB to develop Photosoft treatment for HPV | 24/02/24 | 2 | 1.0K | |||
|
|||||||
IVX | ASX:IVX - Latest research update on Invion from Pitt Street | 24/02/24 | 2 | 961 | |||
|
|||||||
IVX | Invion's Chair and CEO appointed to Advisory Board of Stanford Medicine CARE | 16/02/24 | 0 | 339 | |||
|
|||||||
IVX | Ann: Activities Report and Appendix 4C | 31/01/24 | 5 | 1.8K | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |